Windtree Therapeutics Inc (WINT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Windtree Therapeutics Inc (WINT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011951
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead development product Aerosurf (lucinactant for inhalation), is an investigational combination drug/device product for the treatment of respiratory distress syndrome (RDS) in premature infants. Its technology platforms comprise a novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant, which is structurally similar to pulmonary surfactant, and proprietary drug delivery technologies for the delivery of aerosolized KL4 surfactant and other inhaled therapies. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.

Windtree Therapeutics Inc (WINT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Windtree Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Windtree Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Windtree Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Windtree Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Windtree Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Windtree Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Discovery Labs Enters into Co-Development Agreement with Battelle Memorial Institute 10
Discovery Labs Amends Agreement with Battelle Memorial Institute 11
Equity Offering 13
Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 13
Discovery Laboratories Completes Public Offering Of Shares For US$50 Million 15
Windtree Therapeutics Inc – Key Competitors 16
Windtree Therapeutics Inc – Key Employees 17
Windtree Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
May 15, 2017: Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates 19
Mar 31, 2017: Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates 21
Aug 10, 2016: Windtree Therapeutics Reports Second Quarter 2016 Financial Results and Provides Key Business Updates 23
May 12, 2016: Windtree Therapeutics Reports First Quarter 2016 Financial Results and Provides Business Updates 25
Mar 24, 2016: Discovery Labs Reports Fourth Quarter 2015 Financial Results and Provides Business Updates 27
Legal and Regulatory 29
Apr 18, 2016: Discovery Labs Changes Name to Windtree Therapeutics 29
Feb 03, 2016: Discovery Labs Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 30
Product News 31
Dec 01, 2016: Windtree Therapeutics Announces Upcoming Presentations at Hot Topics in Neonatology 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Windtree Therapeutics Inc, Medical Equipment, Key Facts, 2016 2
Windtree Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Windtree Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Windtree Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Windtree Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Windtree Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Windtree Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Discovery Labs Enters into Co-Development Agreement with Battelle Memorial Institute 10
Discovery Labs Amends Agreement with Battelle Memorial Institute 11
Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 13
Discovery Laboratories Completes Public Offering Of Shares For US$50 Million 15
Windtree Therapeutics Inc, Key Competitors 16
Windtree Therapeutics Inc, Key Employees 17
Windtree Therapeutics Inc, Other Locations 18
Windtree Therapeutics Inc, Subsidiaries 18

★海外企業調査レポート[Windtree Therapeutics Inc (WINT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OceanaGold Corporation:企業の戦略・SWOT・財務情報
    OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report Summary OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Melinta Therapeutics Inc (MLNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Melinta Therapeutics Inc (Melinta) is a biopharmaceutical company that focuses on the development of novel antibiotics. Its drugs are intended to treat the various bacterial infections. The company's lead product Baxdela (delafloxacin) has been approved by the US FDA as an IV treatment for s …
  • Cancer Research Technology Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • Credit Andorra SA:企業の戦略・SWOT・財務分析
    Credit Andorra SA - Strategy, SWOT and Corporate Finance Report Summary Credit Andorra SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fujifilm Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofi …
  • Japan Display Inc:企業の戦略・SWOT・財務情報
    Japan Display Inc - Strategy, SWOT and Corporate Finance Report Summary Japan Display Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Colby Pharmaceutical Co-製薬・医療分野:企業M&A・提携分析
    Summary Colby Pharmaceutical Company (Colby Pharma) is a biopharma company that focuses on the development of safe and effective small molecule analgesic, anti-inflammatory drug, and immunobiologic products. Its product portfolio includes Oral small molecule analgesics CPC-123 & CPC-111 for post-sur …
  • Renaissance Oil Corp (ROE):企業の財務・戦略的SWOT分析
    Summary Renaissance Oil Corp (Renaissance Oil), formerly San Antonio Ventures Inc is an oil and gas exploration and development company that acquires and develops high potential shale and mature fields in Mexico. The company utilizes seismic technology and advanced structural interpretation for the …
  • Hoteli Maestral d.d.:企業の戦略・SWOT・財務情報
    Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ignyta Inc (RXDX)-医療機器分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • Menlo Therapeutics Inc (MNLO):製薬・医療:M&Aディール及び事業提携情報
    Summary Menlo Therapeutics Inc (Menlo Therapeutics) formerly Tigercat Pharma Inc, is a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions such as psoriasis and prurigo nodularis, a …
  • M3 Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary M3 Biotechnology Inc (M3 Biotech) is a therapeutics company that concentrates on novel platform of pharmaceuticals that modifies growth-factor systems. The company provides therapies primarily for the treatment of neurodegenerative diseases. It develops small molecule modulators with a conce …
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Boursorama SA:企業の戦略・SWOT・財務情報
    Boursorama SA - Strategy, SWOT and Corporate Finance Report Summary Boursorama SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Biofrontera AG (B8F):製薬・医療:M&Aディール及び事業提携情報
    Summary Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic kerat …
  • Tereos:企業の戦略・SWOT・財務情報
    Tereos - Strategy, SWOT and Corporate Finance Report Summary Tereos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Stobart Group Limited (STOB):企業の財務・戦略的SWOT分析
    Stobart Group Limited (STOB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Svenska Cellulosa Aktiebolaget:企業のM&A・事業提携・投資動向
    Svenska Cellulosa Aktiebolaget - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Cellulosa Aktiebolaget Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Showa Aircraft Industry Co., Ltd.:企業の戦略・SWOT・財務分析
    Showa Aircraft Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Aircraft Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Powerco Ltd:企業の戦略的SWOT分析
    Powerco Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆